{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:42:59Z","timestamp":1761129779268,"version":"3.37.3"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI130060","AI1117211","R41 AI155423","R42 AI106375"],"award-info":[{"award-number":["R01 AI130060","AI1117211","R41 AI155423","R42 AI106375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,18]]},"DOI":"10.1093\/cid\/ciaa1360","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T19:14:19Z","timestamp":1599246859000},"page":"e682-e684","source":"Crossref","is-referenced-by-count":11,"title":["Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus <i>aureus<\/i>: Back to Basics in Clinical Care and Guidelines"],"prefix":"10.1093","volume":"72","author":[{"given":"William F","family":"Wright","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C J","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Spellberg","sequence":"additional","affiliation":[{"name":"Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"2021051810405531700_CIT0001","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/2013.jamainternmed.56","article-title":"Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress","volume":"172","author":"Kung","year":"2012","journal-title":"Arch Intern Med"},{"key":"2021051810405531700_CIT0002","article-title":"Vancomycin advanced therapeutic drug monitoring: an exercise in futility or virtuous endeavor to improve drug efficacy and safety?","author":"Dilworth","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"2021051810405531700_CIT0005","doi-asserted-by":"crossref","first-page":"ciaa303","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0006","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3947\/ic.2014.46.1.21","article-title":"Underestimation of the calculated area under the concentration-time curve based on serum creatinine for vancomycin dosing","volume":"46","author":"Jin","year":"2014","journal-title":"Infect Chemother"},{"key":"2021051810405531700_CIT0008","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":"Association between vancomycin trough concentration and area under the concentration-time curve in neonates","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021051810405531700_CIT0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0000000000000190","article-title":"Evaluation of target attainment of vancomycin area under the curve in children with methicillin-resistant Staphylococcus aureus bacteremia","volume":"37","author":"Hahn","year":"2015","journal-title":"Ther Drug Monit"},{"key":"2021051810405531700_CIT0010","first-page":"41","article-title":"Vancomycin AUC\/MIC and corresponding troughs in a pediatric population","volume":"22","author":"Kishk","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2021051810405531700_CIT0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FTD.0000000000000359","article-title":"Is trough concentration of vancomycin predictive of the area under the curve? A clinical study in elderly patients","volume":"39","author":"Bel Kamel","year":"2017","journal-title":"Ther Drug Monit"},{"key":"2021051810405531700_CIT0012","first-page":"801","article-title":"Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?","volume":"72","author":"De Cock","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021051810405531700_CIT0013","doi-asserted-by":"crossref","first-page":"e02535-16","DOI":"10.1128\/AAC.02535-16","article-title":"Establishment of an AUC 0\u201324 threshold for nephrotoxicity is a step towards individualized vancomycin dosing for methicillin-resistant Staphylococcus aureus bacteremia","volume":"61","author":"Chavada","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021051810405531700_CIT0014","doi-asserted-by":"crossref","first-page":"e01647-17","DOI":"10.1128\/AAC.01647-17","article-title":"Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration-time curve in neonates","volume":"62","author":"Tseng","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021051810405531700_CIT0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/INF.0000000000001943","article-title":"Optimizing vancomycin monitoring in pediatric patients","volume":"37","author":"Alsultan","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2021051810405531700_CIT0016","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diagmicrobio.2018.06.022","article-title":"Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population","volume":"92","author":"Turner","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021051810405531700_CIT0017","article-title":"Desired vancomycin trough concentration to achieve an AUC 0\u201324 \/MIC \u2265400 in Chinese children with complicated infectious diseases","author":"Zhang","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2021051810405531700_CIT0018","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FTD.0000000000000622","article-title":"Examining the relationship between vancomycin area under the concentration time curve and serum trough levels in adults with presumed or documented staphylococcal infections","volume":"41","author":"Clark","year":"2019","journal-title":"Ther Drug Monit"},{"key":"2021051810405531700_CIT0019","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jcph.1498","article-title":"Optimizing vancomycin use through 2-point AUC-based therapeutic drug monitoring in pediatric patients","volume":"59","author":"Suchartlikitwong","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"2021051810405531700_CIT0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcp.14144","article-title":"Population pharmacokinetics of vancomycin in obesity: finding the optimal dose for (morbidly) obese individuals","volume":"86","author":"Smit","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2021051810405531700_CIT0021","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijid.2019.12.036","article-title":"Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: a clinical pharmacokinetic study","volume":"92","author":"Issaranggoon Na Ayuthaya","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2021051810405531700_CIT0022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12098-019-03162-5","article-title":"AUC- vs. trough-guided monitoring of vancomycin in infants","volume":"87","author":"Alsultan","year":"2020","journal-title":"Indian J Pediatr"},{"key":"2021051810405531700_CIT0023","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2334-14-183","article-title":"Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the phase 3 ATTAIN studies","volume":"14","author":"Barriere","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2021051810405531700_CIT0025","doi-asserted-by":"crossref","first-page":"ofz538","DOI":"10.1093\/ofid\/ofz538","article-title":"Multicenter cohort of patients with methicillin-resistant Staphylococcus aureus bacteremia receiving daptomycin plus ceftaroline compared with other MRSA treatments","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021051810405531700_CIT0026","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","article-title":"Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens","volume":"40","author":"Raad","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0027","doi-asserted-by":"crossref","first-page":"e01078-19","DOI":"10.1128\/AAC.01078-19","article-title":"Antimicrobial activity of exebacase (Lysin CF-301) against the most common causes of infective endocarditis","volume":"63","author":"Watson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021051810405531700_CIT0028","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"2021051810405531700_CIT0029","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkr301","article-title":"Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Walraven","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021051810405531700_CIT0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021051810405531700_CIT0031","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/649572","article-title":"Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?","volume":"201","author":"Lalueza","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1360\/34047589\/ciaa1360.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/10\/e682\/37950835\/ciaa1360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/10\/e682\/37950835\/ciaa1360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T11:00:05Z","timestamp":1621335605000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/10\/e682\/5903055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,9]]},"published-print":{"date-parts":[[2021,5,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1360","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2021,5,15]]},"published":{"date-parts":[[2020,9,9]]}}}